{"pageContent": "Background: Chemotherapy regimens that target microtubular trafficking were repeatedly found to be active in the treatment of hormone refractory prostate cancer patients, but disease responses were reportedly short-lived on average.", "metaData": {"source": "The Utility of Molecular Imaging in Prostate Cancer\nhttps://pubmed.ncbi.nlm.nih.gov/26894753/"}}